Global Medical Marijuana Market 2018-2022

About Medical Marijuana

The global medical marijuana market covers the use of legally procured marijuana for the treatment of crucial symptoms of various chronic diseases impacting the global population. Serious injuries, migraines, back injuries resulting in fractures, arthritis, nerve damages, infections, and fibromyalgia are some conditions that cause chronic pain. Medical marijuana is taken by patients either orally, through inhalation, smoking, or through marijuana-infused edibles.

The analysts forecast the global medical marijuana market to grow at a CAGR of 21.11% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the global medical marijuana market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

Americas

APAC

EMEA

The report, Global Medical Marijuana Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

Aurora Cannabis

GW Pharmaceuticals

mCig

Medical Marijuana

United Cannabis

Market drivers

Increasing use of cannabis for medical purposes

For a full, detailed list, view the full report

Market challenges

High cost of cannabis testing products

For a full, detailed list, view the full report

Market trends

Emergence of luxury cannabis products

For a full, detailed list, view the full report

Key questions answered in this report

What will the market size be in 2022 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.

PART 01: EXECUTIVE SUMMARYPART 02: SCOPE OF THE REPORTPART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

Market ecosystem

Market characteristics

Market segmentation analysis

PART 05: MARKET SIZING

Market definition

Market sizing 2017

Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS

Bargaining power of buyers

Bargaining power of suppliers

Threat of new entrants

Threat of substitutes

Threat of rivalry

Market condition

PART 07: MARKET SEGMENTATION BY APPLICATION

Segmentation by application

Comparison by application

Global medical marijuana market by chronic pain

Global medical marijuana market by nausea

Global medical marijuana market by others

Market opportunity by application

PART 08: CUSTOMER LANDSCAPE

PART 09: REGIONAL LANDSCAPE

Geographical segmentation

Regional comparison

Medical marijuana market in Americas

Medical marijuana market in EMEA

Medical marijuana market in APAC

Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

Market drivers

Market challenges

PART 12: MARKET TRENDS

Emergence of luxury cannabis products

Increased public and private funding in cannabis industry

Increasing promotional activities

PART 13: VENDOR LANDSCAPE

Overview

Landscape disruption

PART 14: VENDOR ANALYSIS

Vendors covered

Vendor classification

Market positioning of vendors

Aurora Cannabis

GW Pharmaceuticals

mCig

Medical Marijuana

United Cannabis

Other prominent vendors

PART 15: APPENDIX

List of abbreviation

List of Exhibits

Exhibit 01: Parent market
Exhibit 02: Global legal cannabis market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global medical marijuana market - Market size and forecast 2017-2022 ($ bn)
Exhibit 09: Global medical marijuana market - Year over year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2022
Exhibit 18: Global medical marijuana market by application - Market share 2017-2022 (%)
Exhibit 19: Comparison by application
Exhibit 20: Global medical marijuana market by chronic pain - Market size and forecast 2017-2022 ($ bn)
Exhibit 21: Global medical marijuana market by chronic pain - Year over year growth 2018-2022 (%)
Exhibit 22: Global medical marijuana market by nausea - Market size and forecast 2017-2022 ($ bn)
Exhibit 23: Global medical marijuana market by nausea - Year over year growth 2018-2022 (%)
Exhibit 24: Global medical marijuana market by others - Market size and forecast 2017-2022 ($ bn)
Exhibit 25: Global medical marijuana market by others - Year over year growth 2018-2022 (%)
Exhibit 26: Market opportunity by application
Exhibit 27: Customer landscape
Exhibit 28: Global medical marijuana market by region - Market share 2017-2022 (%)
Exhibit 29: Regional comparison
Exhibit 30: Medical marijuana market in Americas - Market size and forecast 2017-2022 ($ bn)
Exhibit 31: Medical marijuana market in Americas - Year over year growth 2018-2022 (%)
Exhibit 32: Top three countries in Americas
Exhibit 33: Medical marijuana market in EMEA - Market size and forecast 2017-2022 ($ bn)
Exhibit 34: Medical marijuana market in EMEA - Year over year growth 2018-2022 (%)
Exhibit 35: Top three countries in EMEA
Exhibit 36: Medical marijuana market in APAC - Market size and forecast 2017-2022 ($ bn)
Exhibit 37: Medical marijuana market in APAC - Year over year growth 2018-2022 (%)
Exhibit 38: Top three countries in APAC
Exhibit 39: Market opportunity
Exhibit 40: Various diseases and associated symptoms improved by cannabis
Exhibit 41: List of approved medications containing medical marijuana
Exhibit 42: Approximate NIH funding for cannabinoid research ($ millions)
Exhibit 43: Digital engagement of some vendors through Twitter
Exhibit 44: Vendor landscape
Exhibit 45: Landscape disruption
Exhibit 46: Vendors covered
Exhibit 47: Vendor classification
Exhibit 48: Market positioning of vendors
Exhibit 49: Vendor overview
Exhibit 50: Aurora Cannabis - Business segments
Exhibit 51: Aurora Cannabis - Organizational developments
Exhibit 52: Aurora Cannabis - Geographic focus
Exhibit 53: Aurora Cannabis - Segment focus
Exhibit 54: Aurora Cannabis - Key offerings
Exhibit 55: Vendor overview
Exhibit 56: GW Pharmaceuticals - Business segments
Exhibit 57: GW Pharmaceuticals - Organizational developments
Exhibit 58: GW Pharmaceuticals - Geographic focus
Exhibit 59: GW Pharmaceuticals - Segment focus
Exhibit 60: GW pharmaceuticals - Key offerings
Exhibit 61: Vendor overview
Exhibit 62: mCig - Business segments
Exhibit 63: mCig - Organizational developments
Exhibit 64: mCig - Geographic focus
Exhibit 65: mCig - Segment focus
Exhibit 66: mCig - Key offering
Exhibit 67: Vendor overview
Exhibit 68: Medical Marijuana - Business segments
Exhibit 69: Medical Marijuana - Organizational developments
Exhibit 70: Medical Marijuana - Geographic focus
Exhibit 71: Medical Marijuana - Segment focus
Exhibit 72: Medical Marijuana - Key offering
Exhibit 73: United Cannabis overview
Exhibit 74: United Cannabis - Business segments
Exhibit 75: United Cannabis - Organizational developments
Exhibit 76: United Cannabis - Geographic focus
Exhibit 77: United Cannabis - Segment focus
Exhibit 78: United Cannabis - Key offerings

Executive Summary

New Report Released: - Global Medical Marijuana Market 2018-2022

The author of the report recognizes the following companies as the key players in the global medical marijuana market: Aurora Cannabis, GW Pharmaceuticals, mCig, Medical Marijuana, and United Cannabis.

Commenting on the report, an analyst from the research team said: “One trend in the market is emergence of luxury cannabis products. Since the consumption of cannabis through smoking can be harmful, many vendors selling luxury cannabis products that make controlled consumption of cannabis beneficial to the users have emerged in the market.”

According to the report, one driver in the market is increasing use of cannabis for medical purposes. Cannabis used for medicinal purposes is referred to as medical marijuana or medical cannabis. This term refers to utilizing the whole, unprocessed cannabis plant or its extracts to treat a variety of symptoms and conditions. It can also be obtained through synthetic derivatives of cannabis. Medical cannabis contains a variety of compounds that are collectively referred to as cannabinoids.

Further, the report states that one challenge in the market is high cost of cannabis testing products. Although vendors in the cannabis testing market such as Agilent Technologies, Merck, Perkin Elmer, Shimadzu Corporation, and Thermo Fisher Scientific offer high-quality analytical products, they are all high-priced and thus, pose a challenge for cannabis testing laboratories. Medium and small-scale testing laboratories are cramped for budgets required for testing equipment.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.